Hite Christopher

CIK 00018142382 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001814238

Recent Transactions

18 trades

Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-11-05+6,168→ 658,510 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-08-06+3,696→ 652,342 total
Award
Royalty Pharma plc$RPRX
Class E Ordinary Shares
2025-05-16+1,238,789→ 1,238,789 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-05-08+48,646→ 648,646 total
Conversion
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2025-02-14−30,000→ 86,641 total
Conversion
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-02-14+300,000→ 600,000 total
Conversion
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2024-05-13+300,000→ 370,000 total
Conversion
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2024-05-13−30,000→ 541 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−1,848→ 0 total
Disposition from Tender
ACCELERON PHARMA INC
Common Stock
2021-11-19−930→ 0 total
Disposition to Issuer
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-11-19−10,267→ 0 total
Sale
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2021-03-23$469.86/sh−31,959→ 30,541 total
Award
ACCELERON PHARMA INC
Common Stock
2021-01-29+930→ 930 total
Award
ACCELERON PHARMA INC
Option to Purchase Common Stock
2021-01-29+1,848→ 1,848 total
Purchase
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2020-06-18$28.00/sh+70,000→ 70,000 total
Award
Royalty Pharma plc$RPRX
ICAI Interests
2020-06-15+116,100→ 116,100 total
Award
Royalty Pharma plc$RPRX
LP interests in RPI US Partners 2019, LP
2020-06-15+62,500→ 62,500 total
Award
ACCELERON PHARMA INC
Option to Purchase Common Stock
2020-06-04+10,267→ 10,267 total

Companies

Recent Filings

Address

C/O ROYALTY PHARMA PLC 110 E. 59TH STREET

NEW YORK, NY, 10022

View on SEC.gov